We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-1.39%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33.8M
Cap. Flow
% of AUM
9.8%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$4.2M |
| 2 |
Procter & Gamble
PG
|
+$3.18M |
| 3 |
Apple
AAPL
|
+$2.96M |
| 4 |
Booking.com
BKNG
|
+$2.81M |
| 5 |
Diageo
DEO
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$3.37M |
| 2 |
NVIDIA
NVDA
|
+$3.35M |
| 3 |
On Holding
ONON
|
+$2.92M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$2.64M |
| 5 |
ASML
ASML
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Zentalis Pharmaceuticals
ZNTL
$307M
| $36.3K | 0.01% |
1,809
+1,030
| +132% | +$26.1K |
|
252
Agios Pharmaceuticals
AGIO
$2.04B
| $35.4K | 0.01% |
1,429
+700
| +96% | +$18.5K |
|
|
MRUS
253
DELISTED
Merus
MRUS
| $34.8K | 0.01% |
1,477
+867
| +142% | +$21K |
|
254
BioCryst Pharmaceuticals
BCRX
$2.71B
| $34.4K | 0.01% |
4,865
+2,388
| +96% | +$17.2K |
|
255
AbCellera Biologics
ABCL
$3.18B
| $34.1K | 0.01% |
7,423
+3,638
| +96% | +$22.1K |
|
256
Maravai LifeSciences
MRVI
$861M
| $33.9K | 0.01% |
3,391
+1,662
| +96% | +$18.3K |
|
257
Myriad Genetics
MYGN
$309M
| $33.7K | 0.01% |
2,101
+1,032
| +97% | +$19.6K |
|
258
Summit Therapeutics
SMMT
$12B
| $33.5K | 0.01% |
17,903
+8,758
| +96% | +$16.7K |
|
259
Rhythm Pharmaceuticals
RYTM
$8.1B
| $33.4K | 0.01% |
1,458
+713
| +96% | +$16K |
|
260
Zai Lab
ZLAB
$2.86B
| $33.3K | 0.01% |
1,371
+557
| +68% | +$14.8K |
|
261
Vir Biotechnology
VIR
$1.52B
| $32.3K | 0.01% |
3,448
+1,692
| +96% | +$24.1K |
|
262
Amylyx Pharmaceuticals
AMLX
$2.6B
| $31.7K | 0.01% |
1,730
+850
| +97% | +$18K |
|
|
SAGE
263
DELISTED
Sage Therapeutics
SAGE
| $31.5K | 0.01% |
1,531
+748
| +96% | +$21.6K |
|
264
Xencor
XNCR
$1.72B
| $31.2K | 0.01% |
1,548
+756
| +95% | +$17.2K |
|
265
Mirum Pharmaceuticals
MIRM
$6.04B
| $31.2K | 0.01% |
986
+488
| +98% | +$13.4K |
|
266
Unity
U
$19.6B
| $30.2K | 0.01% |
961
-8,229
| -90% | -$317K |
|
|
ETNB
267
DELISTED
89bio
ETNB
| $30K | 0.01% |
1,945
+990
| +104% | +$16.6K |
|
268
ANI Pharmaceuticals
ANIP
$1.73B
| $29.8K | 0.01% |
513
+248
| +94% | +$14.3K |
|
269
Twist Bioscience
TWST
$7.85B
| $29.8K | 0.01% |
1,470
+721
| +96% | +$15.8K |
|
270
Iovance Biotherapeutics
IOVA
$3.05B
| $28.9K | 0.01% |
6,356
+3,414
| +116% | +$22.3K |
|
|
GRFS
271
Grifois
GRFS
$5.4B
| $28.6K | 0.01% |
3,132
+1,618
| +107% | +$15.8K |
|
272
Aurinia Pharmaceuticals
AUPH
$2.06B
| $28.5K | 0.01% |
3,673
+1,798
| +96% | +$17.6K |
|
273
MannKind Corp
MNKD
$1.24B
| $28.5K | 0.01% |
6,892
+3,428
| +99% | +$15.4K |
|
274
Geron
GERN
$1.01B
| $28.5K | 0.01% |
13,426
+6,757
| +101% | +$18.3K |
|
|
MORF
275
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $28.4K | 0.01% |
1,238
+638
| +106% | +$33.5K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2023 Portfolio in Review
As of Q3 2023, China Universal Asset Management Company held 466 positions worth $345M, up 6.5% from $324M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company deployed $33.8M of net new capital in Q3 2023, opening 14 new positions and adding to 365 existing holdings. Its largest new stake was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $3.37M trimmed.
- China Universal Asset Management Company's largest Q3 2023 buy was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
- China Universal Asset Management Company added most to Amazon in Q3 2023, an estimated $4.2M increase.
- China Universal Asset Management Company's biggest Q3 2023 reduction was TSMC, cutting an estimated $3.37M.
- China Universal Asset Management Company fully exited Carnival Corporation Ltd in Q3 2023, selling an estimated $2.64M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $345M portfolio in Q3 2023.
- China Universal Asset Management Company opened 14 new positions and closed 20 in Q3 2023.
- China Universal Asset Management Company's portfolio value rose 6.5% quarter-over-quarter to $345M.
Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.